课题基金 / 基金详情

Study of early ischemic myocardial damage in forensic pathology

Study of early ischemic myocardial damage in forensic pathology
早期缺血性心肌损伤的法医病理学研究
批准号:
10670393
负责人:
NAKASONO Ichiro
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

NAKASONO Ichiro的其他基金

相似基金

相关文献

中文摘要
翻译
早期缺血性心肌损伤的尸检诊断一直是法医学实践中的一个复杂问题。我们检查了长崎大学医学院法医学系共63例尸检获得的心脏组织病理学结果。死因依次为自然死亡、窒息、创伤性休克和头部损伤。在常规组织学苏木精-伊红(H&E)染色和Mallory磷钨酸苏木素(PTAH)染色的基础上,应用细胞间黏附分子、补体C9和肌钙蛋白I(心肌特异性蛋白)的抗体进行免疫组织化学染色。纤维连接蛋白和补体C9的成分被认为在心肌损伤时可能在心肌细胞中表达,而肌钙蛋白I被认为在心肌损伤时可能从心肌细胞中丢失。这些标记物的免疫组织化学染色模式因病例而异。这些结果反映了这三种标志物在心肌损伤过程中的敏感转变。此外,我们使用74例法医尸检心脏的每一块左心室块,用补体成分C9的免疫组织化学技术检测早期缺血性心肌损伤。结果得出结论,心肌细胞上的C9染色是早期缺血性心肌损伤的可靠标记物,因为它足够敏感,只需从每个患者的一个区块就能检测到。此外,虽然有11例标本在福尔马林中固定了一年以上,但C9的免疫染色没有受到影响。在回顾性法医标本中,C9的这种免疫染色是一种简单且有价值的检测早期缺血性心肌损伤的方法。在回顾性法医标本中,C9的这种免疫染色是一种简单且有价值的检测早期缺血性心肌损伤的方法。
英文摘要
The postmortem diagnosis of early ischemic myocardial damage has lain as intricate problem on forensic practice.We examined the histopathological findings of heart of a total of sixty-three cases obtained in the autopsies at the Department of Legal Medicine in Nagasaki University School of Medicine. Their causes of death were natural death, asphyxia, traumatic shock and head injury. We used the immunohistochemical staining by the antibodies to Fibronectin, i.e. the intercellular adhesion molecule, component of complement C9 and Troponin I, i.e. the specific protein of myocardium, in addition to conventional histological staining with hematoxylin and eosin (H&E) and Mallory's phosphotungstic acid hematoxylin (PTAH) method. Fibronectin and component of complement C9 are considered that they may be expressed in cardiomyocytes at myocardial damage and Troponin I is regarded as it may loss from cardiomyocytes at myocardial damage conversely. The immunohistochemical staining pattern of these markers were varied from case to case. These results suggested that these findings reflected the sensitive transitions of these three markers during myocardial damage.Furthermore, we used each single block of left ventricle from 74 forensic autopsy hearts to detect the early ischemic myocardial damage with immunohistochemical technique for complement component C9. The results lead the conclusion that C9 staining on cardiomyocytes is a reliable marker for early ischemic myocardial damage since it was sensitive enough to detect from just one block of each patient. Moreover, although in eleven cases the samples were fixed in formalin over one year, the immunostaining of C9 was not affected. This immunostaining for C9 is simple and valuable to detect early ischemic myocardial damage in retrospective forensic specimens. This immunostaining for C9 is simple and valuable to detect early ischemic myocardial damage in retrospective forensic specimens.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
折原義行他: "法医剖検例における心筋障害の免疫組織学的検討"法医病理. 6.
Yoshiyuki Orihara等:“法医尸检病例中心肌损伤的免疫组织学检查”法医病理学6。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
The establishment of new marker to diagnose the wound age
  • 批准号:
    21390216
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.48万
  • 财政年份:
    2009
  • 负责人:
    NAKASONO Ichiro
  • 依托单位:
The expression of a Novel Stress Protein "150-kD a Oxygen Regulated Protein (ORP-150) "in Forensic Autopsy Cases
  • 批准号:
    14370156
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $9.09万
  • 财政年份:
    2002
  • 负责人:
    NAKASONO Ichiro
  • 依托单位:
Study of receptor and transporter of neruotransmitter in forensic pathology
  • 批准号:
    11557035
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 资助金额:
    $7.55万
  • 财政年份:
    1999
  • 负责人:
    NAKASONO Ichiro
  • 依托单位:
Forensic Neuropathological Study of Fibroblast Growth Factor and Stress Protein
  • 批准号:
    06670462
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.34万
  • 财政年份:
    1994
  • 负责人:
    NAKASONO Ichiro
  • 依托单位:
国内基金
海外基金
e-Heart仿真平台及关键技术研究
  • 批准号:
    60571025
  • 项目类别:
    面上项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2005
  • 负责人:
    王宽全
  • 依托单位: